Is the quality of evidence in health technology assessment deteriorating over time? A case study on cancer drugs in Australia.

Gao, Yuan; Laka, Mah; Merlin, Tracy

Gao, Yuan; Laka, Mah; Merlin, Tracy.

Afiliação

Gao Y; Adelaide Health Technology Assessment, School of Public Health, University of Adelaide, Adelaide, SA, Australia.
Laka M; Adelaide Health Technology Assessment, School of Public Health, University of Adelaide, Adelaide, SA, Australia.
Merlin T; Adelaide Health Technology Assessment, School of Public Health, University of Adelaide, Adelaide, SA, Australia.

Int J Technol Assess Health Care ; 39(1): e28, 2023 May 18.

Article em En | MEDLINE | ID: mdl-37198927

Assuntos

Antineoplásicos; Neoplasias; Humanos; Avaliação da Tecnologia Biomédica; Antineoplásicos/uso terapêutico; Comitês Consultivos; Neoplasias/tratamento farmacológico; Austrália

Palavras-chave

cancer medicines; decision-making; evidence quality; evidence-based policy; health technology assessment; reimbursement; risk of bias

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Health_technology_assessment / Prognostic_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Int J Technol Assess Health Care Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google